However, the increased of MK commitment regulator as MAF39 coupled to decreased of MK differentiation inhibitors, like IFNAR1, PTEN and SOCS640–42 could favor the higher PLT count in CALR-mutated subjects compared to JAK2V617F-positive ET patients. The gene discussed is PTEN; the disease is essential thrombocythemia.